The CFO's repeated selling pattern in 2026, combined with this new intent to sell, warrants monitoring for further insider sales ahead of the next earnings report. The small size relative to market cap suggests limited immediate price impact, but the cumulative selling by a key executive could signal a lack of conviction at current elevated levels. Traders should watch for any acceleration in insider selling or a Form 4 filing confirming the sale.
Price Chart
Executive Summary
Oscar Health CFO Richard Scott Blackley filed a Form 144 to sell 18,750 shares of common stock, with an estimated aggregate market value of $614,250 based on a filing price of $32.76. The shares were acquired via restricted stock unit vesting for services rendered. While the dollar amount is modest relative to the company's $9.7B market cap, the CFO's intent to sell is notable given the stock's strong recent performance and the insider's prior selling pattern in 2026. The filing signals potential near-term selling pressure from a key executive, but the small size limits material impact on the stock's trajectory.
Key Facts
- CFO Richard Scott Blackley filed Form 144 to sell 18,750 shares of Oscar Health common stock.
- Estimated aggregate market value of the proposed sale is $614,250 (based on $32.76 per share).
- Shares were acquired via restricted stock unit vesting on 12/01/2024 (14,498 shares) and 03/01/2024 (7,015 shares) for services rendered.
- The filing is an advance notice of intent to sell; the sale may not occur.
- Blackley has sold shares multiple times in 2026, including sales on 05/14, 05/18, and 06/02, totaling over 240,000 shares sold prior to this filing.
- Oscar Health has a $9.7B market cap and 47% analyst bullish rating (2 Strong Buy, 7 Buy, 9 Hold).
Financial Impact
Proposed sale of 18,750 shares valued at ~$614,250, representing less than 0.01% of market cap.
Risk Factors
- Insider selling by CFO may signal lack of confidence in near-term valuation or fundamentals.
- Form 144 is only an intent to sell; the sale may not be executed.
- Stock has appreciated significantly (historical reports show large positive moves), creating potential for profit-taking by insiders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-355649 |
| Document: 0001193125-26-355649-index.html | 0001193125-26-355649 |
| Document: 0001193125-26-355649.txt | 0001193125-26-355649 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $32.34 $31.29 | ▼ −3.25% | ▼ −6.08% | $30.94 (−4.33%) |
Aug 18, 2026 6w ago | 144 | $32.30 $31.24 | ▲ +3.28% | ▲ +2.89% | $30.94 (+4.21%) |
Aug 10, 2026 7w ago | 144 | $27.97 $31.28 | ▲ +11.83% | ▲ +12.24% | $30.94 (+10.62%) |
Jul 6, 2026 12w ago | Insider Cluster | $31.44 $30.54 | ▲ +2.86% | ▲ +3.35% | $30.94 (+1.59%) |
Jul 1, 2026 13w ago | Insider Cluster | $31.90 $31.12 | ▲ +2.45% | ▲ +2.71% | $30.94 (+3.01%) |
Jun 11, 2026 16w ago | Institutional Cluster | $28.91 $28.27 | ▼ −2.21% | ▼ −2.65% | $30.94 (+7.02%) |
Jun 8, 2026 16w ago | 8-K | $27.39 $29.14 | ▲ +6.39% | ▲ +4.28% | $30.94 (+12.96%) |
Jun 4, 2026 17w ago | Insider Cluster | $24.51 $28.26 | ▲ +15.30% | ▲ +14.73% | $30.94 (+26.23%) |
Jun 2, 2026 17w ago | 144 | $20.50 $27.85 | ▼ −35.85% | ▼ −39.67% | $30.94 (−50.93%) |
Jun 2, 2026 17w ago | 8-K | $21.14 $27.22 | ▲ +28.76% | ▲ +31.73% | $30.94 (+46.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access